Vaccination alone or in combination with pyridostigmine promotes and prolongs activation of stress-activated kinases induced by stress in the mouse brain

Journal of Neurochemistry

Volumn 93, Issue 4, 2005, Pages 1010-1020

  Wang, Dechun ^a   Perides, George ^b   Liu, Ya Fang ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

Gulf war illness; JNK; MKK4; Pyrid ostigmine; Stress; Vaccination

Indexed keywords

CASPASE 3; KEYHOLE LIMPET HEMOCYANIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; PYRIDOSTIGMINE; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; ENZYME ACTIVATION; MOUSE; NEUROLOGIC DISEASE; NONHUMAN; PATHOGENESIS; PERSIAN GULF SYNDROME; PRIORITY JOURNAL; STRESS; VACCINATION;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; CASPASE 3; CASPASES; CHOLINESTERASE INHIBITORS; DRUG SYNERGISM; ENZYME ACTIVATION; HEMOCYANIN; IMMUNOHISTOCHEMISTRY; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASE 13; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PYRIDOSTIGMINE BROMIDE; STRESS; SWIMMING; TIME FACTORS; VACCINATION;

EID: 18844362601     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2005.03093.x     Document Type: Article

References (57)

1. Abdel-Rahman A., Shetty A. K. and Abou-Donia M. B. (2002) Disruption of the blood-brain barrier and neuronal cell death in cingulate cortex, dentate gyrus, thalamus, and hypothalamus in a rat model of Gulf-War syndrome. Neurobiol. Dis. 10, 306-326.
2. Barrett D., Gray G., Doebbeling B., Clauw D. and Reese W. (2002) The prevalence of symptoms and symptoms-based conditions among Gulf war veterans: current status of research findings. Epidemiol. Rev. 24, 218-227.
3. Brimacombe M., Zhang Q. W., Lange G. and Natelson B. H. (2003) Immunological variables mediate cognitive dysfunction in Gulf war veterans but not civilians with chronic fatigue syndrome. Neuroimmunomodulation 10, 93-100.
4. Caughlan A., Newhouse K., Namgung U. and Xia Z. (2004) Chlorpyrifos induces apoptosis in rat cortical neurons that is regulated by a balance between p38 and ERK/JNK MAP kinases. Toxicol. Sci. 78, 125-134.
5. Chun H. S., Gibson G. E., DeGiorgio L. A., Zhang H., Kidd V. J. and Son J. H. (2001) Dopaminergic cell death induced by MPP (+), oxidant and specific neurotoxicants shares the common molecular mechanism. J. Neurochem. 76, 1010-1021.
6. Cleare A. J., Miell E., Heap E., Sookdeo S., Young L., Maihi G. S. and O'Keane V. (2001) Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome and the effect of low dose hydrocortisone therapy. J. Clin. Endocrinol. Metab. 86, 3545-3554.
7. ATP channel. Annu. Rev. Physiol. 62, 79-109.
8. Coker W. J., Bhatt B., Blatchley N. F. and Graham J. T. (1999) Clinical findings for the first 1000 Gulf war veterans in the ministry of defence's medical assessment program. BMJ. 318, 290-294.
9. De Kloet E. R., Vregdenhil E., Oitzl M. S. and Joels M. (1998) Brain corticosteroid receptor balance in health and disease. Endocrinol. Rev. 19, 269-301.
10. Dong C., Davis R. J. and Flavell R. A. (2002) MAP kinases in the immune response. Annu. Rev. Immunol. 20, 55-72.
11. Ellin R. I. and Kaminskis A. (1989) Carbamoylated enzyme reversal as means of predicting pyridostigmine protection against soman. J. Pharm. Pharmacol. 41, 633-636.
12. Esposito P., Basu S., Letoumeau R., Jacobson S. and Theoharides T. C. (2003) Stress-induced dura vascular permeability does not develop in mast cell-deficient and neurokinin-1 receptor knockout mice. Brain Res. 968, 192-198.
13. Garcia M., Vanhoutte P., Pages C., Besson M. J., Brouillet E. and Caboche J. (2002) The mitochondrial toxin 3-nitropropionic acid induces striatal neurodegeneration via a c-Jun N-terminal kinase/c-Jun module. J. Neurosci. 22, 2174-2184.
14. Gray G. C., Gray G. D., Kang H. K., Graham J. T. and Scott K. C. (2004) After more than 10 years of Gulf war veteran medical evaluations, what have we learned? Am. J. Prev Med. 26, 443-452.
15. Haley R. W. and Kurt T. L. (1997) Self-reported exposure to neurotoxic chemical combinations in the Gulf war: a cross-sectional epidemiologic study. JAMA 277, 231-237.
16. Han T. (1975) Specific effect of neuraminidase on blastogenic response of sensitized lymphocytes. Immunology 28, 283-286.
17. Hotopf M., David A., Hull L., Ismail K., Unwin C. and Wessely S. (2000) Role of vaccinations as risk factors for ill health in veterans of the Gulf war: cross sectional study. BMJ. 320, 1363-1367.
18. Hotopf M., David A., Hull L., Nikalaou V., Unwin C. and Wessely S. (2003) Gulf war illness-better, worse, or just the same? A cohort study. BMJ. 327, 1370-1172.
19. Hoy J. B., Comell J. A., Karlix J. L., Tebbett I. R. and van Haaren F. (2000) Interactions of pyridostigmine bromide, DEET, and permethrin alter locomotor behavior of rats. Vet. Hum. Toxicol. 42, 65-71.
20. Hyames K. C., Wignall F. S. and Roswell R. (1996) War syndrome and their evaluation: from the U.S. civil war to the Persian Gulf war. Ann. Intern. Med. 125, 398-704.
21. Ishoy T., Suadicani P., Guldager B., Appleyard M., Hein H. O. and Gyntelberg F. (1999) State of health after deployment in the Persian Gulf. The Danish Gulf war Study. Dan Med. Bull. 46, 416-419.
22. Jones E., Hodgins-Vermaas R., McCartney H., Everitt B., Beech C., Poyter F., Palmer I., Hyams K. and Wessely S. (2002) Post-combat syndromes from the Boer war to Gulf war: a cluster analysis of their nature and attribution. BMJ. 324, 321-324.
23. Kang H. K., Mahan C. M., Lee K. Y., Magee C. A. and Murphy F. M. (2000) Illness among United States veterans of the Gulf war: a population-based survey of 30,000 veterans. J. Occup Environ. Med. 42, 491-501.
24. Kang H. K., Natelson B. H., Mahan C. M., Lee K. Y. and Murphy F. M. (2003) Post-traumatic stress disorder and chronic fatigue syndrome-like illness among Gulf war veterans: a population-based survey of 30,000 veterans. Am. J. Epidemiol. 157, 141-148.
25. Kant G. J., Bauman R. A., Feaster S. R., Anderson S. M., Saviolakis G. A. and Garcia G. E. (2001) The combined effects of pyridostigmine and chronic stress on brain and blood acetylcholinesterase, corticosterone, prolactin, and alternation performance in rats. Pharmacol. Biochem. Behav 70, 209-218.
26. Karin M. and Change L. (2001) AP-1-glucocorticoid receptor crosstalk taken to a higher level. J. Endocrinol. 169, 447-451.
27. Lee J. K., Hwang W. S., Lee Y. D. and Han P. L. (1999) Dynamic expression of SEK1 suggests multiple roles of the gene during embryogenesis and in adult brain of mice. Mol. Brain Res. 66, 133-140.
28. Liu Y. F. (1998) Expression of polyglutamine-expanded huntingtin activates the SEK1-JNK pathway and induces apoptosis of hippocampal neuronal cells. J. Biol. Chem. 273, 28 873-28 877.
29. Liu Y. F. Dorow D. and Marshall J. (2000) Activation of MLK2-mediated signalling cascade by polyglutamine-expanded huntingtin. J. Biol. Chem. 275, 19 035-19 040.
30. Liu Y. F., Bertram K., Perides G., McEwen B. S. and Wang D. (2004) Stress induces activation of stress-activated kinase in the mouse brain. J. Neurochm 89, 1034-1043.
31. Marino M. T., Schuster E. G., Brueckner R. P., Lin E., Kaminskis A. and Lasseter K. C. (1998) Population pharmacokinetics and pharmacodynamics of pyridostigmine bromide for prophylaxis against nerve agents in humans. J. Clin. Pharmacol. 38, 227-235.
32. Maxwell D. M., Brecht K. M., Doctor B. P. and Wolfe A. D. (1993) Comparison of antidote protection against soman by pyridostigmine, HI-1 and acetylcholinesterase. J. Pharmacol. Exp Ther 264, 1085-1089.
33. McEwen B. S. (1998) Protective and damaging effects of stress mediators. New Engl. J. Med. 338, 171-179.
34. McLaughlin B., Hartnett K. A., Erhardt J. A., Legos J. J., White R. F., Barone F. C. and Aizenman E. (2003) Caspase 3 activation is essential for neuroprotection in preconditioning. Proc. Natl Acad. Sci. USA 100, 715-720.
35. Mielke K. and Herdegen T. (2000) JNK and p38 stresskinases-degenerative effectors of signal-transduction-cascades in the nervous system. Prog. Neurobiol. 61, 45-60.
36. Nicolson G. L., Nasralla M. Y., Haier J. and Pomfret J. (2002) High frequency of systemic mycoplasmal infections in Gulf war veterans and civilians with Amyotrophic Lateral Sclerosis (ALS). J. Clin. Neurosci. 9, 525-529.
37. Nisenbaum R., Ismail K., Weesely S., Unwin C., Hull L. and Reeves W. C. (2004) Dichotomous factor analysis of symptoms reported by UK and US veterans of the 1991 Gulf war.
38. Peng J., Mao X. O., Stevenson F. F., Hau M. and Anderson J. K. (2004) The hericide paraquat induces dopaminergic nigral apoptosis through sustained activation of the JNK pathway. J. Biol. Chem 279, 32 626-32 632.
39. Plotsky P. M. (1991) Pathways to the secretion of adrenocorticotropin: a view from the portal. J. Neuroendocrinol. 3, 1-9.
40. Rincon M., Flavell R. A. and Davis R. J. (2001) Signal transduction by MAP kinases in T lymphocytes. Oncogene 20, 2490-2497.
41. Rothwell N. J. and Hopkins S. J. (1995) Cytokines and the nervous system II: actions and mechanisms of action. Trends Neurosci. 18, 130-136.
42. Samoilov M. O., Lazarevich E. V., Semenov D. G., Mokrushin A. A., Tyul'kova E. I., Romanovskii D. Y., Milyakova E. A. and Dudkin K. N. (2003) The adaptive effects of hypoxic preconditioning of brain neurons. Neurosci. Behav Physiol. 33, 1-11.
43. Saporito M. S., Thomas B. A. and Scott R. W. (2000) MPTP activates c-Jun NH (2)-terminal kinase and its upstream regulatory kinase MKK4 in nigrostriatal neurons in vivo. J. Neurochem. 75, 1200-1208.
44. Schaller B. and Graf R. (2002) Cerebral ischemic pre-conditioning. J. Neurol. 249, 1503-1511.
45. Scheffe H. (1953) A method for judging all contrasts in the analysis of variance. Biometrica 40, 87-104.
46. Schmidt E. D., Aguilera G., Binnekade R. and Tiders F. J. H. (2003) Single administration of interleukin-1 increased corticotropin releasing hormone and corticortropin releasing hormone-receptor mRNA in the hypothalamis paraventricular nucleus which paralleled long-lasting (weeks) sensitization to emotional stress. Neuroscience 116, 275-283.
47. Schulte G., Sommerschild H., Yang J., Tokuno S., Goiny M., Lovdahl C., Johansson B., Fredholm B. B. and Valen G. (2004) Adenosine A receptors are necessary for protection of the murine heart by remote, delayed adaptation to ischaemia. Acta Physiol. Scand. 182, 133-143.
48. Schumm W. R., Reppert E. J., Jurich A. P. et al. (2002) Pyridostigmine bromide and the long-term subjective health status of a sample of over 700 male Reserve Component Gulf war era veterans. Psychol Rep 90, 639-653.
49. Shaulian E. and Karin M. (2002) AP-1 as a regulator of cell life and death. Nat Cell Biol. 4, E131-E136.
50. Skowera A., Hotopf M., Sawicka E. et al. (2004) Cellular immune activation in Gulf war veterans. J. Clin. Immunol. 24, 66-73.
51. Spencer P. S., McCauley L. A., Lapidus J. A., Lasarev M., Joos S. K. and Storzbach D. (2001) Self-reported exposures and their association with unexplained illness in a population-based case-control study of Gulf war veterans. J. Occup Environ. Med. 43, 1041-1056.
52. The Iowa Persian Gulf Study Group (1997) Self-reported illness and health status among Gulf war veterans: a population-based study. JAMA 277, 238-245.
53. Tortarolo M., Veglianese P., Calvaresi N., Botturi A., Rossi C., Giorgini A., Migheli A. and Bendotti C. (2003) Persistant activation of p38-mitogen-activated protein kinase in a mouse model of familial amyotrophic lateral sclerosis correlates with disease progression. Mol Cell Neurosci. 23, 180-192.
54. Wang L. H., Besirli C. G., Johnson E. M. Jr et al. (2004) Mixed-lineage kinase: a target for the prevention of neurodegeneration. Annu. Rev. Pharmacol. Toxicol. 44, 451-474.
55. Watanobe H., Nasushita R. and Takebe K. (1995) A study on the role of circulating prostaglandin E2 in the adrnecorticotropin to intravenous administration of interleukin-1 beta in the rat. Neuroendocrinology 62, 596-600.
56. Xu Y., Day T. A. and Buller K. M. (1999) The central amygdala modulates hypothalamic-pituitary-adrenal axis responses to systemic interleukin-1 beta administration. Neuroscience 94, 175-183.
57. Zhuang X., Silverman A. J. and Silver R. (1996) Brain mast cell deregulation regulates blood-brain barrier. J. Neurobiol. 31, 393-403. 1.